Skip to content
PipDig
EUR/USDLoading…GBP/USDLoading…USD/JPYLoading…XAU/USDLoading…BTC/USDLoading…

Forex News

Calidi Biotherapeutics gets NYSE American notice

Calidi Biotherapeutics received a NYSE American notice on Sept. 21, 2026, and remains below compliance.

By Fiona McAllister, Global Markets EditorPipDig Newsroom
  • Calidi Biotherapeutics received the notice on Sept. 21, 2026.
  • The stock is currently below compliance.
  • Calidi has until March 21, 2028 to regain compliance.

Notice

Calidi Biotherapeutics said it received a notice from NYSE American on Sept. 21, 2026. The stock is below compliance.

A dark silhouette of a single young sapling on a small hill against a soft pre-dawn sky, positioned in the upper two-thirds with the bottom third left empty.
Calidi Biotherapeutics gets NYSE American notice

The company has until March 21, 2028 to regain compliance.

Listing standard

NYSE American’s continued listing standards include a $4.0 million stockholders’ equity requirement. Calidi Biotherapeutics has a plan submission deadline of Oct. 21, 2026.

Source: GlobeNewswire,